Health ❯ Healthcare ❯ Medical Research
Type 1 Diabetes Type 2 Diabetes GLP-1 Receptor Agonists Diabetic Retinopathy Ethics in Research Stent Complications Continuous Glucose Monitoring Retinal Degeneration Clinical Trials Gastroesophageal Reflux Disease Alpha Cells Insulin Therapy GLP-1 Drugs Stem Cell Therapy Dementia Type 1 Diabetes Prevention Patient Care Eye Diseases Maturity-Onset Diabetes of the Young (MODY) American Diabetes Association Smart Insulin Diabetic Foot Ulcers Research Ethics Pancreas Transplantation Beta Cell Mass Measurement Wound Healing Optic Nerve Disorders Freedom of Expression Space Medicine Type 2 Diabetes Mellitus Medication
Want to see what podcasts are saying about this topic? Search across 125K+ podcasts. Explore Radar
Researchers published the analysis on July 1, 2026 and say randomized trials are needed to test whether GLP‑1 receptor agonists causally reduce mortality, amputations and hospital care for high‑risk patients
